176 related articles for article (PubMed ID: 22360714)
1. Pharmacoeconomics.
Hughes DA
Br J Clin Pharmacol; 2012 Jun; 73(6):968-72. PubMed ID: 22360714
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.
Campbell F; Thokala P; Uttley LC; Sutton A; Sutton AJ; Al-Mohammad A; Thomas SM
Health Technol Assess; 2014 Sep; 18(59):1-120. PubMed ID: 25265259
[TBL] [Abstract][Full Text] [Related]
3. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
[TBL] [Abstract][Full Text] [Related]
4. Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs.
Robertson J; Lang D; Hill S
J Clin Pharm Ther; 2003 Feb; 28(1):73-9. PubMed ID: 12605622
[TBL] [Abstract][Full Text] [Related]
5. Risk-based, 6-monthly and 24-monthly dental check-ups for adults: the INTERVAL three-arm RCT.
Clarkson JE; Pitts NB; Goulao B; Boyers D; Ramsay CR; Floate R; Braid HJ; Fee PA; Ord FS; Worthington HV; van der Pol M; Young L; Freeman R; Gouick J; Humphris GM; Mitchell FE; McDonald AM; Norrie JD; Sim K; Douglas G; Ricketts D
Health Technol Assess; 2020 Nov; 24(60):1-138. PubMed ID: 33215986
[TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial.
Brittenden J; Cotton SC; Elders A; Tassie E; Scotland G; Ramsay CR; Norrie J; Burr J; Francis J; Wileman S; Campbell B; Bachoo P; Chetter I; Gough M; Earnshaw J; Lees T; Scott J; Baker SA; MacLennan G; Prior M; Bolsover D; Campbell MK
Health Technol Assess; 2015 Apr; 19(27):1-342. PubMed ID: 25858333
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.
Sutcliffe P; Connock M; Pulikottil-Jacob R; Kandala NB; Suri G; Gurung T; Grove A; Shyangdan D; Briscoe S; Maheswaran H; Clarke A
Health Technol Assess; 2013 Nov; 17(53):1-499, v-vi. PubMed ID: 24280231
[TBL] [Abstract][Full Text] [Related]
8. Drug therapy: safety, effectiveness, and economics.
Brandys J
Przegl Lek; 2001; 58(4):226-8. PubMed ID: 11450340
[TBL] [Abstract][Full Text] [Related]
9. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
Ungar WJ
Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
[TBL] [Abstract][Full Text] [Related]
10. A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study.
Lomas J; Schmitt L; Jones S; McGeorge M; Bates E; Holland M; Cooper D; Crowther R; Ashmore M; Rojas-Rueda D; Weatherly H; Richardson G; Bojke L
BMJ Open; 2016 Jun; 6(6):e010686. PubMed ID: 27329439
[TBL] [Abstract][Full Text] [Related]
11. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
[TBL] [Abstract][Full Text] [Related]
12. Decision-makers' preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity.
Linley WG; Hughes DA
Pharmacoeconomics; 2013 Apr; 31(4):345-55. PubMed ID: 23516033
[TBL] [Abstract][Full Text] [Related]
13. Economic Evaluation of Hospital and Community Pharmacy Services.
Gammie T; Vogler S; Babar ZU
Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
[TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective.
Brereton N; Bodger K; Kamm MA; Hodgkins P; Yan S; Akehurst R
J Med Econ; 2010 Mar; 13(1):148-61. PubMed ID: 20141380
[TBL] [Abstract][Full Text] [Related]
15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
16. The Arthroplasty Candidacy Help Engine tool to select candidates for hip and knee replacement surgery: development and economic modelling.
Price A; Smith J; Dakin H; Kang S; Eibich P; Cook J; Gray A; Harris K; Middleton R; Gibbons E; Benedetto E; Smith S; Dawson J; Fitzpatrick R; Sayers A; Miller L; Marques E; Gooberman-Hill R; Blom A; Judge A; Arden N; Murray D; Glyn-Jones S; Barker K; Carr A; Beard D
Health Technol Assess; 2019 Jun; 23(32):1-216. PubMed ID: 31287051
[TBL] [Abstract][Full Text] [Related]
17. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.
McCormack K; Wake B; Perez J; Fraser C; Cook J; McIntosh E; Vale L; Grant A
Health Technol Assess; 2005 Apr; 9(14):1-203, iii-iv. PubMed ID: 15842951
[TBL] [Abstract][Full Text] [Related]
19. Should NICE's threshold range for cost per QALY be raised? No.
Raftery J
BMJ; 2009 Jan; 338():b185. PubMed ID: 19171562
[No Abstract] [Full Text] [Related]
20. Should NICE's threshold range for cost per QALY be raised? Yes.
Towse A
BMJ; 2009 Jan; 338():b181. PubMed ID: 19171561
[No Abstract] [Full Text] [Related]
[Next] [New Search]
